Atossa Therapeutics Inc (NASDAQ:ATOS)

2.41
Delayed Data
As of Sep 23
 +0.06 / +2.55%
Today’s Change
0.76
Today|||52-Week Range
5.08
+53.50%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +211.20% increase from the last price of 2.41.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$0.00
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.77%
 
 
 
 
 
 
Growthannually 28.57%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.